Divi's Laboratories Limited
DIVISLAB
Rangering i aksjer
#909
Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India,... Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India, operates globally in the production and distribution of generic active pharmaceutical ingredients (APIs), intermediate chemicals, and nutraceuticals. The company's market footprint encompasses India, the United States, Asia, Europe, and other international regions. In addition to its core product lines, Divi's offers bespoke synthesis services for APIs and intermediates. It also provides a diverse range of carotenoids and markets various vitamins, catering to the nutritional, pharmaceutical, food and beverage, and animal feed industries. The firm was formerly known as Divi's Research Center before rebranding to Divi's Laboratories Limited in 1994.
Aksjekurs
$100.28
Sist synkronisert: 2026-10-19
Markedsverdi
$26.62B
Endring (1 dag)
-0.41%
Endring (1 år)
34.01%
Land
IN
Handel Divi's Laboratories Limited (DIVISLAB)
Kategori
Healthcare
Inntekter for Divi's Laboratories Limited (DIVISLAB)
Inntekter i Jun 2026 TTM: $1.24B
Ifølge de nyeste økonomiske rapportene til Divi's Laboratories Limited er selskapets nåværende inntekter (TTM) $1.24B. I 2024 hadde selskapet inntekter på $934.96M en nedgang sammenlignet med inntektene i 2023, som var $942.90M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Divi's Laboratories Limited fra 2005 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $1.24B | 13.27% |
| 2025 | $1.09B | 17.03% |
| 2024 | $934.96M | -0.84% |
| 2023 | $942.90M | -18.66% |
| 2022 | $1.16B | 23.73% |
| 2021 | $936.88M | 33.39% |
| 2020 | $702.35M | 0.99% |
| 2019 | $695.47M | 16.36% |
| 2018 | $597.68M | -4.38% |
| 2017 | $625.04M | 9.65% |
| 2016 | $570.02M | 14.19% |
| 2015 | $499.20M | 18.17% |
| 2014 | $422.45M | 7.02% |
| 2013 | $394.74M | 7.38% |
| 2012 | $367.61M | 24.43% |
| 2011 | $295.42M | 40.91% |
| 2010 | $209.66M | -9.82% |
| 2009 | $232.50M | -90.99% |
| 2008 | $2.58B | 1,444.12% |
| 2007 | $167.15M | 95.34% |
| 2006 | $85.57M | 7.56% |
| 2005 | $79.55M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 433.49% |
IN
|
